Head-to-head comparison between the non-vitamin K antagonist oral anticoagulants for treatment of venous thrombo-embolism: do we really need it?-Reference-Cited by-同舟云学术

Head-to-head comparison between the non-vitamin K antagonist oral anticoagulants for treatment of venous thrombo-embolism: do we really need it?

Published:2018-07-31 Issue:4 Volume:4 Page:228-229
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Vinereanu Dragoş¹

Affiliation:

1. University of Medicine and Pharmacy ‘Carol Davila’, Bucharest, Romania; and Department of Cardiology, University and Emergency Hospital, Bucharest, Bucharest, Romania

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/4/4/228/25719581/pvy024.pdf

Reference9 articles.

1. Oral apixaban for the treatment of acute venous thromboembolism;Agnelli;N Engl J Med,2013

2. Dabigatran versus warfarin in the treatment of acute venous thromboembolism;Schulman;N Engl J Med,2009

3. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism;Hokusai-VTE Investigators;N Engl J Med,2013

4. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism;EINSTEIN–PE Investigators;N Engl J Med,2012

5. Oral rivaroxaban for symptomatic venous thromboembolism;EINSTEIN Investigators;N Engl J Med,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on subpopulations of atrial fibrillation patients;European Heart Journal - Cardiovascular Pharmacotherapy;2020-05-01

2. Lipids and antithrombotic treatment;European Heart Journal - Cardiovascular Pharmacotherapy;2020-03-01

3. The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials;European Heart Journal - Cardiovascular Pharmacotherapy;2019-08-29